[ad_1]
The latest global data indicate that the number of cases and deaths due to the disease will increase in the region faster than average. In the country, the annual number of cases will reach one million by 2040.
Different sectors warn of the need to take steps to improve access to cancer treatment. The improvement of infrastructure, financial means, human resources and the availability of treatments are the most cited solutions.
Every two minutes, cancer is diagnosed in five people in Latin America. The region has 1.4 million new cases per year and the disease continues to grow. In September 2018, the International Agency for Research on Cancer (IARC), linked to the World Health Organization (WHO), updated the World Cancer Observatory and drew an alarming picture: the incidence of the disease is expected to increase by 63% worldwide
In less developed regions, such as Latin America, where early diagnosis and access to treatment are more difficult, the scenario is even worse: the number of cases should be reduced. from 73% in the next 21 years, to 2.5 million per year, and the number of deaths will almost double to 1.3 million deaths per year.
At the same time, access to health care in the region faces serious problems: according to a Lancet study, more than 156 million people die each year from lack of access to health services. The growing need for care faces fragmented health systems, lack of infrastructure, human resources, diagnosis, treatment and funding.
In Brazil, the number of cases of the disease is expected to reach nearly one million by 2040, number 78.% higher than the current. The estimate is that the number of deaths per year doubles, reaching 476,000. "Our country, having continental dimensions and regional inequalities, access to health in general and to the prevention and treatment of cancer in particular, is difficult, "said the clinical director of Amor Hospital, Dr. Paulo de Tarso Oliveira. and Castro. The hospital is one of the largest philanthropic institutions for the prevention and treatment of cancer in the country
. The doctor also states that it is difficult to perform basic preventive tests and start treatment. The lack of access to tests to detect tumors quickly is one of the factors that increase the risks in the country. In 2017, for example, 8.8 million Brazilian women were unable to routinely undergo routine mammograms in the unified health system (SUS), funded by the government, or 76% of the total target population.
This means that three out of four women have been without a procedure, which is the primary means of early detection of bad cancer. This is the type of cancer that kills most women. The scenario is the worst recorded in the last five years, said Antônio Luiz Frbadon, president of the Brazilian Society of Mastology. To reach the entire female population aged 50 and over, it would be necessary to perform 11.5 million exams, but only 2.7%. millions were made, 24% of the total. The World Health Organization recommends covering this type of examination to at least 70% of the population.
Claudineia Custódio de Oliveira is among those who have not pbaded the examination by the public system. In February 2018, the doctor indicated a mammogram to determine if the mbad she had in her bad was malignant. To pbad the SUS exam, she should wait about five months. He ended up paying for not only the mammogram but all the necessary tests before the start of treatment. "In 21 days, I've done what it would take a year for the SUS," she says. Eight months later, she was already in the final phase of treatment.
The president of the Brazilian Society of Mastology said that in recent years, the number of information on bad cancer in the population had increased significantly, thanks to campaigns such as October Rose . Even in this case, at least half of the cases are still detected at an advanced stage. Progress has also been made in the prevention of other types of tumors, such as cervix uteri, with the inclusion of the HPV vaccine in the public calendar. However, staff and equipment are not available for early diagnosis and for early treatment to begin. The most serious case concerns tumors of the lungs, trachea and bronchi, for which more than 80% of diagnoses are diagnosed at an advanced stage.
[ad_2]
Source link
